Lung Cancer Clinical Trial

Perceptions on Expected Outcomes of Immunotherapy in Advanced Non-small Cell Lung Cancer Patients With Poor Performance Status

Summary

To better understand your feelings and expectations about immunotherapy

View Full Description

Full Description

Primary Objective:

1. To compare expectations of survival benefit from immunotherapy between advanced non-small cell lung cancer (NSCLC) patients with poor performance status (PS) and their oncologists. We hypothesize that, compared to their oncologists, patients will have expectations for greater likelihood of survival beyond 2 years.

Secondary Objectives:

To compare expectations of therapeutic benefit of immunotherapy between advanced NSCLC patients with poor PS and their oncologists. We hypothesize that, compared to their oncologists, patients will have expectations for greater likelihood of cure, quality of life improvement, and lower likelihood of adverse events.
To qualitatively describe the priorities and preferences for information of advanced NSCLC patients with poor PS when considering immunotherapy treatment.
To evaluate the associations between discrepant expectations with patients' sociodemographic and clinical characteristics.
To compare patient and oncologist expectations with actual treatment outcomes and survival

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients being considered for or within 2 months of starting immunotherapy for advanced NSCLC
Patient ≥18 years of age
ECOG ≥2
Cognitively able to understand consent and complete questionnaire as determined by the interviewer at the time of study enrollment
English speaking
Willing to participate in the study and sign informed consent
The study will include the oncologists that treat non-small cell lung cancer

Exclusion Criteria:

Treatment for curative intent
Presence of Delirium (as determined by score >13 on MDAS 46, appendix A)

Study is for people with:

Lung Cancer

Estimated Enrollment:

110

Study ID:

NCT05634551

Recruitment Status:

Not yet recruiting

Sponsor:

M.D. Anderson Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

M D Anderson Cancer Center
Houston Texas, 77030, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

110

Study ID:

NCT05634551

Recruitment Status:

Not yet recruiting

Sponsor:


M.D. Anderson Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider